KAYLA AUCOIN: Open Payments
NPI 1780152652 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,572 in 180 payments from 26 companies in 2025. Trend: 2023 $2,418 · 2024 $3,158 · 2025 $3,572
Food & beverage: $3,572
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $595 |
| Biogen, Inc. | 15 | $336 |
| PFIZER INC. | 19 | $320 |
| UCB, Inc. | 15 | $251 |
| JAZZ PHARMACEUTICALS INC. | 11 | $232 |
| Aucta Pharmaceuticals, Inc. | 9 | $198 |
| SK Life Science, Inc. | 8 | $196 |
| Neurelis, Inc. | 4 | $189 |
| Lundbeck LLC | 16 | $188 |
| Lilly USA, LLC | 9 | $170 |
Products named: UBRELVY, NURTEC ODT, QULIPTA, EPIDIOLEX, Motpoly XR, VALTOCO, TYSABRI, VYEPTI.
Industry payments across LA — which companies pay providers there.
